Alpha Cognition (ACOG) Income towards Parent Company (2023 - 2025)
Alpha Cognition's (ACOG) quarterly Income towards Parent Company came in at -$8.0 million in Q4 2025, down 225.08% year-on-year from $6.4 million in Q4 2024, and down 706.81% quarter-over-quarter from $1.3 million in Q3 2025.
Alpha Cognition (ACOG) Income towards Parent Company (2023 - 2025) Analysis & Trends
Alpha Cognition's Income towards Parent Company history runs 3 years deep, the most recent figure standing at -$8.0 million for Q4 2025.
- On a quarterly basis, Income towards Parent Company fell 225.08% year-over-year to -$8.0 million in Q4 2025; TTM through Dec 2025 was -$21.9 million, a 91.34% decrease from a year earlier, with the FY2025 full-year figure at -$42.6 million, down 51.69% from the prior year.
- Income towards Parent Company eased to -$8.0 million in Q4 2025 per ACOG's latest filing, from $1.3 million in the prior quarter.
- Across five years, Income towards Parent Company topped out at $1.3 million in Q3 2025 and bottomed at -$13.2 million in Q2 2025.
- The 3-year median for Income towards Parent Company is -$2.5 million (2024), against an average of -$3.8 million.
- Biggest YoY gain for Income towards Parent Company was 170.87% in 2025; the steepest drop was 523.93% in 2025.
- Year by year, Income towards Parent Company stood at -$2.4 million in 2023, then decreased by 1.01% to -$2.5 million in 2024, then plunged by 225.08% to -$8.0 million in 2025.
- Per Business Quant, the three latest ACOG Income towards Parent Company figures stand at -$8.0 million (Q4 2025), $1.3 million (Q3 2025), and -$13.2 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Alpha Cognition | 146.84 Mn | 80.73 Mn | 2.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -8.00 Mn |
| Sep 30, 2025 | 1.32 Mn |
| Jun 30, 2025 | -13.20 Mn |
| Mar 31, 2025 | -2.01 Mn |
| Dec 31, 2024 | -2.46 Mn |
| Sep 30, 2024 | -1.86 Mn |
| Jun 30, 2024 | -2.12 Mn |
| Mar 31, 2024 | -5.00 Mn |
| Dec 31, 2023 | -2.44 Mn |
| Sep 30, 2023 | -2.77 Mn |
| Jun 30, 2023 | -2.73 Mn |